Atlas Trials

Dapagliflozin Effect on Cardiovascular Outcomes in Haemodialysis for End Stage Renal Disease

Clinical trial NCT04764097 · WITHDRAWN

Trial details

NCT number
NCT04764097
Sponsor
Tan Tock Seng Hospital
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Cardiovascular DiseasesEnd Stage Renal Disease
Start date
2021-06-01
Primary completion
2025-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.